CTOs on the Move


 
High Touch, Inc. is a Wichita, KS-based company in the Software and Internet sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Mvix Digital Signage

Mvix provides Enterprise digital signage solutions for healthcare, corporate communications, education, restaurants, and more.

Immertec

With real-time virtual surgery training, Immertecs VR platform removes physical barriers that restrict the adoption of modern medical devices and procedures.

Interpres Security

Interpres is a Threat Informed Defense Surface Management Platform that fuses and operationalizes prioritized adversarial techniques, tactics, and procedures with your unique threat profile, your unique security stack and finished intelligence to identify coverage gaps, prioritize actions, optimize defenses and reduce risk. Interpres Security makes security performance intelligible and provable for the enterprise with a comprehensive new approach to managing the defense surface. With Interpres, security teams can take a threat-informed perspective to understand what their current tools can detect and defend against, identify gaps and inefficiencies, and iteratively improve their security posture with a data-driven and custom tailored approach.

Tassat

Tassat offers the TassatPay, The First Blockchain Payment System at a Major Bank.

Immunome

Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.